These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20923686)

  • 21. A single immunization with soluble recombinant trimeric hemagglutinin protects chickens against highly pathogenic avian influenza virus H5N1.
    Cornelissen LA; de Vries RP; de Boer-Luijtze EA; Rigter A; Rottier PJ; de Haan CA
    PLoS One; 2010 May; 5(5):e10645. PubMed ID: 20498717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigenic analysis of H5N1 highly pathogenic avian influenza viruses circulating in Egypt (2006-2012).
    Ibrahim M; Eladl AH; Sultan HA; Arafa AS; Abdel Razik AG; Abd El Rahman S; El-Azm KI; Saif YM; Lee CW
    Vet Microbiol; 2013 Dec; 167(3-4):651-61. PubMed ID: 24139721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Broadening the H5N3 Vaccine Immunogenicity against H5N1 Virus by Modification of Neutralizing Epitopes.
    Rajesh Kumar S; Chelvaretnam S; Tan Y; Prabakaran M
    Viruses; 2017 Dec; 10(1):. PubMed ID: 29295514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective efficacy of an inactivated chimeric H5 avian influenza vaccine against H5 highly pathogenic avian influenza virus clades 2.3.4.4 and 2.3.2.1.
    Li J; Hou G; Wang Y; Wang S; Cheng S; Peng C; Jiang W
    J Gen Virol; 2018 Dec; 99(12):1600-1607. PubMed ID: 30358528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic analysis of avian influenza A viruses isolated from domestic waterfowl in live-bird markets of Hanoi, Vietnam, preceding fatal H5N1 human infections in 2004.
    Jadhao SJ; Nguyen DC; Uyeki TM; Shaw M; Maines T; Rowe T; Smith C; Huynh LP; Nghiem HK; Nguyen DH; Nguyen HK; Nguyen HH; Hoang LT; Nguyen T; Phuong LS; Klimov A; Tumpey TM; Cox NJ; Donis RO; Matsuoka Y; Katz JM
    Arch Virol; 2009; 154(8):1249-61. PubMed ID: 19578928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
    Jadhao SJ; Lee CW; Sylte M; Suarez DL
    Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of lentiviral pseudotypes with influenza H5N1 hemagglutinin and their performance in neutralization assays.
    Wang W; Xie H; Ye Z; Vassell R; Weiss CD
    J Virol Methods; 2010 May; 165(2):305-10. PubMed ID: 20153374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polyvalent DNA vaccines expressing HA antigens of H5N1 influenza viruses with an optimized leader sequence elicit cross-protective antibody responses.
    Wang S; Hackett A; Jia N; Zhang C; Zhang L; Parker C; Zhou A; Li J; Cao WC; Huang Z; Li Y; Lu S
    PLoS One; 2011; 6(12):e28757. PubMed ID: 22205966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel humanized antibody neutralizes H5N1 influenza virus via two different mechanisms.
    Tan Y; Ng Q; Jia Q; Kwang J; He F
    J Virol; 2015 Apr; 89(7):3712-22. PubMed ID: 25609802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigenic Fingerprinting of Antibody Response in Humans following Exposure to Highly Pathogenic H7N7 Avian Influenza Virus: Evidence for Anti-PA-X Antibodies.
    Khurana S; Chung KY; Coyle EM; Meijer A; Golding H
    J Virol; 2016 Oct; 90(20):9383-93. PubMed ID: 27512055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of amino acids in highly pathogenic avian influenza H5N1 virus hemagglutinin that determine avian influenza species specificity.
    Li Z; Liu Z; Ma C; Zhang L; Su Y; Gao GF; Li Z; Cui L; He W
    Arch Virol; 2011 Oct; 156(10):1803-12. PubMed ID: 21744000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of cross-clade monoclonal antibodies against H5N1 highly pathogenic avian influenza virus and their application to the antigenic analysis of diverse H5 subtype viruses.
    Gronsang D; Bui AN; Trinh DQ; Bui VN; Nguyen KV; Can MX; Omatsu T; Mizutani T; Nagai M; Katayama Y; Thampaisarn R; Ogawa H; Imai K
    Arch Virol; 2017 Aug; 162(8):2257-2269. PubMed ID: 28405766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presence of serum antibodies to influenza A subtypes H5 and N1 in swans and ibises in French wetlands, irrespective of highly pathogenic H5N1 natural infection.
    Niqueux E; Guionie O; Schmitz A; Hars J; Jestin V
    Avian Dis; 2010 Mar; 54(1 Suppl):502-8. PubMed ID: 20521685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pseudoparticle neutralization is a reliable assay to measure immunity and cross-reactivity to H5N1 influenza viruses.
    Alberini I; Del Tordello E; Fasolo A; Temperton NJ; Galli G; Gentile C; Montomoli E; Hilbert AK; Banzhoff A; Del Giudice G; Donnelly JJ; Rappuoli R; Capecchi B
    Vaccine; 2009 Oct; 27(43):5998-6003. PubMed ID: 19665606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antigenic diversity and cross-reactivity of avian influenza H5N1 viruses in Egypt between 2006 and 2011.
    El-Shesheny R; Kayali G; Kandeil A; Cai Z; Barakat AB; Ghanim H; Ali MA
    J Gen Virol; 2012 Dec; 93(Pt 12):2564-2574. PubMed ID: 22956735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigenic analysis of highly pathogenic avian influenza virus H5N1 sublineages co-circulating in Egypt.
    Watanabe Y; Ibrahim MS; Ellakany HF; Kawashita N; Daidoji T; Takagi T; Yasunaga T; Nakaya T; Ikuta K
    J Gen Virol; 2012 Oct; 93(Pt 10):2215-2226. PubMed ID: 22791605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccination with virus-like particles containing H5 antigens from three H5N1 clades protects chickens from H5N1 and H5N8 influenza viruses.
    Kapczynski DR; Tumpey TM; Hidajat R; Zsak A; Chrzastek K; Tretyakova I; Pushko P
    Vaccine; 2016 Mar; 34(13):1575-1581. PubMed ID: 26868083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A biosensor based on electroactive dipyrromethene-Cu(II) layer deposited onto gold electrodes for the detection of antibodies against avian influenza virus type H5N1 in hen sera.
    Jarocka U; Sawicka R; Stachyra A; Góra-Sochacka A; Sirko A; Zagórski-Ostoja W; Sączyńska V; Porębska A; Dehaen W; Radecki J; Radecka H
    Anal Bioanal Chem; 2015 Oct; 407(25):7807-14. PubMed ID: 26297459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of a Recombinant Turkey Herpesvirus H5 Vaccine Against Challenge With H5N1 Clades 1.1.2 and 2.3.2.1 Highly Pathogenic Avian Influenza Viruses in Domestic Ducks (Anas platyrhynchos domesticus).
    Pantin-Jackwood MJ; Kapczynski DR; DeJesus E; Costa-Hurtado M; Dauphin G; Tripodi A; Dunn JR; Swayne DE
    Avian Dis; 2016 Mar; 60(1):22-32. PubMed ID: 26953940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation of recombinant phage antibodies targeting the hemagglutinin cleavage site of highly pathogenic avian influenza virus.
    Dong J; Sakurai A; Nomura N; Park EY; Shibasaki F; Ueda H
    PLoS One; 2013; 8(4):e61158. PubMed ID: 23577205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.